Technical Articles

FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera蛋白:多发性骨髓瘤免疫治疗的绿色导航标
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein: A Green Navigation Beacon for Immunotherapy in Multiple Myeloma
发布时间 2025-12-02
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein is a high-performance fluorescently labeled fusion protein with critical value in immunotherapy research for hematologic malignancies such as multiple myeloma.
View details
  • Cancer
  • SLAMF7/CRACC/CD319
  • Fc Chimera
  • Multiple Myeloma
  • Hematologic Malignancies
Total 1
  • 1
Go to